Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2012 1
2013 1
2019 4
2020 10
2021 9
2022 12
2023 6
2024 5
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy in cervix cancer.
Attademo L, Tuninetti V, Pisano C, Cecere SC, Di Napoli M, Tambaro R, Valabrega G, Musacchio L, Setola SV, Piccirillo P, Califano D, Spina A, Losito S, Greggi S, Pignata S. Attademo L, et al. Among authors: musacchio l. Cancer Treat Rev. 2020 Nov;90:102088. doi: 10.1016/j.ctrv.2020.102088. Epub 2020 Aug 7. Cancer Treat Rev. 2020. PMID: 32827839 Review.
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer.
Pacholczak-Madej R, Bartoletti M, Musacchio L, Püsküllüoglu M, Blecharz P, Lorusso D. Pacholczak-Madej R, et al. Among authors: musacchio l. Expert Rev Anticancer Ther. 2024 Aug;24(8):717-729. doi: 10.1080/14737140.2024.2367472. Epub 2024 Jun 14. Expert Rev Anticancer Ther. 2024. PMID: 38863432 Review.
PARP Inhibitors Resistance: Mechanisms and Perspectives.
Giudice E, Gentile M, Salutari V, Ricci C, Musacchio L, Carbone MV, Ghizzoni V, Camarda F, Tronconi F, Nero C, Ciccarone F, Scambia G, Lorusso D. Giudice E, et al. Among authors: musacchio l. Cancers (Basel). 2022 Mar 10;14(6):1420. doi: 10.3390/cancers14061420. Cancers (Basel). 2022. PMID: 35326571 Free PMC article. Review.
Advances in treatment strategies for low-grade serous ovarian cancer.
Musacchio L, Lorusso D, Sabetta G, Giustozzi A, Giudice E, Cannizzaro MC, Perri MT, Fagotti A, Salutari V. Musacchio L, et al. Cancer Treat Rev. 2025 Nov;140:103019. doi: 10.1016/j.ctrv.2025.103019. Epub 2025 Sep 5. Cancer Treat Rev. 2025. PMID: 40934817 Review.
Nitrogen biobank for cardiovascular research.
Mercuri A, Turchi S, Borghini A, Chiesa MR, Lazzerini G, Musacchio L, Zirilli O, Andreassi MG. Mercuri A, et al. Among authors: musacchio l. Curr Cardiol Rev. 2013 Aug;9(3):253-9. doi: 10.2174/1573403x113099990035. Curr Cardiol Rev. 2013. PMID: 23909635 Free PMC article. Review.
PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.
Musacchio L, Caruso G, Pisano C, Cecere SC, Di Napoli M, Attademo L, Tambaro R, Russo D, Califano D, Palaia I, Muzii L, Benedetti Panici P, Pignata S. Musacchio L, et al. Cancer Manag Res. 2020 Jul 22;12:6123-6135. doi: 10.2147/CMAR.S221001. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801862 Free PMC article. Review.
Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Tronconi F, Nero C, Giudice E, Salutari V, Musacchio L, Ricci C, Carbone MV, Ghizzoni V, Perri MT, Camarda F, Gentile M, Berardi R, Scambia G, Lorusso D. Tronconi F, et al. Among authors: musacchio l. Crit Rev Oncol Hematol. 2022 Dec;180:103851. doi: 10.1016/j.critrevonc.2022.103851. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257537 Review.
52 results